References
- Ramsdell JW, Nachtwey FJ, Moser KM. Bronchial hyperreactivity in chronic obstructive bronchitis. Am Rev Respir Dis 1982: 126(5): 829–32
- Gerrard JW, Cockcroft DW, Mink JT, et al. Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980: 122(4): 577–81
- Kanner RE. The relationship between airways responsiveness and chronic airflow limitation. Chest 1984: 86(1): 54–7
- Morris JF, Temple W. Spirometric “lung age”: estimation for motivating smoking cessation. Prev Med 1985: 14(5): 655–62
- Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and Clonidine: results of a double-blind, randomized trial. JAMA 1988: 259(19): 2863–6
- Braun SR, McKenzie WN, Copeland C, et al. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 1989: 149(3): 544–7
- Webb J, Clark TJ, Chilvers C. Time course of response to prednisolone in chronic airflow obstruction. Thorax 1981: 36(1): 18–21
- Postma DS, Peters I, Steenhuis EJ, et al. Moderately severe chronic airflow obstruction: can corticosteroids slow down obstruction? Eur Respir J 1988: 1(1): 22–6
- Eichenhorn MS, Beauchamp RK, Harper PA, et al. An assessment of three portable peak flow meters. Chest 1982: 82(3): 306–9
- Mitchell DM, Gildeh P, Dimond AH, et al. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation. Thorax 1986: 41(8): 606–10
- Gross N. COPD: a disease of reversible airflow obstruction. Am Rev Respir Dis 1986: 133(5): 725–6
- Anthonisen NR. Wright EC. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986: 133(5): 814–9
- Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984: 39(2): 131–6
- Roche WR, Bessley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989: 1(8637): 520–4